Point taken from the FDA perspective. Even still, if a trial prospective is valid, they can’t (or shouldn’t) keep it from happening just because it is competitive, else we would still be using leeches and doing bloodletting.

I’m talking about the SEC, which has been a topic of conversation here lately and if they, GNBT, is being under investigation, because of other Covid related frauds committed by other (not GNBT) companies. Pfizer got $1.95 billion taxpayer $$$ and needs another $1,000,000,000 in financing. Why?